4//SEC Filing
Krebs Stephanie 4
Accession 0001415889-24-030070
CIK 0001829802other
Filed
Dec 22, 7:00 PM ET
Accepted
Dec 23, 4:15 PM ET
Size
5.5 KB
Accession
0001415889-24-030070
Insider Transaction Report
Form 4
Krebs Stephanie
Chief Business Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-12-20+120,000→ 120,000 totalExercise: $0.45Exp: 2034-12-19→ Common Stock (120,000 underlying)
Footnotes (1)
- [F1]100% of the shares subject to the option shall vest on December 1, 2025, subject to the Reporting Person's continuous service with the Issuer as of such date.
Documents
Issuer
Sensei Biotherapeutics, Inc.
CIK 0001829802
Entity typeother
Related Parties
1- filerCIK 0001998150
Filing Metadata
- Form type
- 4
- Filed
- Dec 22, 7:00 PM ET
- Accepted
- Dec 23, 4:15 PM ET
- Size
- 5.5 KB